JPS6229557A - Dilower alkylphenol derivative - Google Patents
Dilower alkylphenol derivativeInfo
- Publication number
- JPS6229557A JPS6229557A JP16817585A JP16817585A JPS6229557A JP S6229557 A JPS6229557 A JP S6229557A JP 16817585 A JP16817585 A JP 16817585A JP 16817585 A JP16817585 A JP 16817585A JP S6229557 A JPS6229557 A JP S6229557A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- group
- agent
- formula
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 8
- 125000001424 substituent group Chemical group 0.000 claims abstract description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 4
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 3
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 41
- 150000004057 1,4-benzoquinones Chemical class 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 239000003054 catalyst Substances 0.000 abstract description 3
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract description 2
- 239000000043 antiallergic agent Substances 0.000 abstract description 2
- 239000003146 anticoagulant agent Substances 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract description 2
- 239000003435 antirheumatic agent Substances 0.000 abstract description 2
- 229960004676 antithrombotic agent Drugs 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000000903 blocking effect Effects 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000002934 diuretic Substances 0.000 abstract description 2
- 230000000055 hyoplipidemic effect Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 150000003180 prostaglandins Chemical class 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- -1 5ec-butyl Chemical group 0.000 description 159
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 229940005561 1,4-benzoquinone Drugs 0.000 description 1
- ILROLYQPRYHHFG-UHFFFAOYSA-N 1-$l^{1}-oxidanylprop-2-en-1-one Chemical group [O]C(=O)C=C ILROLYQPRYHHFG-UHFFFAOYSA-N 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- RDQSIADLBQFVMY-UHFFFAOYSA-N 2,6-Di-tert-butylbenzoquinone Chemical compound CC(C)(C)C1=CC(=O)C=C(C(C)(C)C)C1=O RDQSIADLBQFVMY-UHFFFAOYSA-N 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- 125000004779 2-chloro-2-fluoroethyl group Chemical group [H]C([H])(*)C([H])(F)Cl 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 description 1
- DOBUKWPISJBXBD-UHFFFAOYSA-N 3-(3,5-ditert-butyl-4-hydroxyanilino)benzoic acid Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(NC=2C=C(C=CC=2)C(O)=O)=C1 DOBUKWPISJBXBD-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DRWRWIXKMYVSPH-UHFFFAOYSA-N Cl.CC(C)(C)c1cccc(O)c1C(C)(C)C Chemical compound Cl.CC(C)(C)c1cccc(O)c1C(C)(C)C DRWRWIXKMYVSPH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-M hydrosulfide Chemical compound [SH-] RWSOTUBLDIXVET-UHFFFAOYSA-M 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002913 oxalic acids Chemical class 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical group N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000006253 t-butylcarbonyl group Chemical group [H]C([H])([H])C(C(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、新規なジ低級アルキルフェノール誘導体及び
その塩に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to novel di-lower alkylphenol derivatives and salts thereof.
来 の 技 術
本発明のジ低級アルキルフェノール誘導体は、文献未載
の新規化合物である。Background of the Invention The di-lower alkylphenol derivative of the present invention is a novel compound that has not been described in any literature.
明が 決しようとする間 点
本発明は、後記するように医薬品として有用な化合物を
提供することを目的とする。SUMMARY OF THE INVENTION The present invention aims to provide compounds useful as pharmaceuticals, as described below.
問題1を解決するための手段
本発明によれば、下記一般式(1)で表わされる化合物
が提供される。Means for Solving Problem 1 According to the present invention, a compound represented by the following general formula (1) is provided.
C式中R1はハロゲン原子、カルボキシル基、水酸基、
アミノ基、シアン基、低級アルキル基、低級アルコキシ
基、ヒドロキシ低級アルキル基、低級アルコキシカルボ
ニル低級アルキル基、カルボキシ低級アルキル基、ハロ
ゲノ置換低級アルキル基、低級アルキルカルボニル基、
低級アルキルチオ基及びフェニルチオ基から選ばれる置
換基の1〜3個を有するフェニル基を示す。In formula C, R1 is a halogen atom, a carboxyl group, a hydroxyl group,
Amino group, cyanogen group, lower alkyl group, lower alkoxy group, hydroxy lower alkyl group, lower alkoxycarbonyl lower alkyl group, carboxy lower alkyl group, halogeno-substituted lower alkyl group, lower alkyl carbonyl group,
It represents a phenyl group having 1 to 3 substituents selected from a lower alkylthio group and a phenylthio group.
R2及びR3は各々同−又は異なって低級アルキル基を
示す。〕
本明細書において、低級アルキル基なる語は、炭素数1
〜6の直鎮状又は分枝鎮状アルキル基を指称するもので
あり、その具体例としては、メチル、エチル、プロピル
、イソプロピル、ブチル、イソブチル、5ec−ブチル
、t−ブチル、ペンチル、ヘキシル基等を例示できる。R2 and R3 are the same or different and each represents a lower alkyl group. ] In this specification, the term lower alkyl group has 1 carbon number
-6 straight or branched alkyl groups, specific examples of which include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, 5ec-butyl, t-butyl, pentyl, and hexyl groups. etc. can be exemplified.
低級アルコキシ基なる語は、上記と同様に炭素数1〜6
の直鎖状又は分枝鎖状アルコキシ基を指称し、その例と
しては、メトキシ、エトキシ、プロポキシ、イソプロポ
キシ、5eC−ブトキシ、t−ブトキシ、ペンチルオキ
シ、ヘキシルオキシ基等を例示できる。The term lower alkoxy group has 1 to 6 carbon atoms as above.
refers to a straight-chain or branched alkoxy group, examples of which include methoxy, ethoxy, propoxy, isopropoxy, 5eC-butoxy, t-butoxy, pentyloxy, hexyloxy, and the like.
ハロゲン原子には、弗素、塩素、臭素及び沃素原子が包
含される。Halogen atoms include fluorine, chlorine, bromine and iodine atoms.
ヒドロキシ低級アルキル基なる語は、上記と同様に炭素
数1〜6の直鎖状又は分枝鎖状のヒドロキシアルキル基
を指称し、その例としてはヒドロキシメチル、1−ヒド
ロキシエチル、2−ヒドロキシエチル、1−ヒドロキシ
プロピル、2−ヒドロキシプロピル、3−ヒドロキシプ
ロピル、2−ヒドロキシ−1−メチルエチル、1−ヒド
ロキシブチル、2−ヒドロキシブチル、3−ヒドロキシ
ブチル、4−ヒドロキシブチル、1−ヒドロキシペンチ
ル、2−ヒドロキシペンチル、3−ヒドロキシペンチル
、4−ヒドロキシペンチル、5−ヒドロキシペンチル、
1−ヒドロキシヘキシル、2−ヒドロキシヘキシル、6
−ヒドロキシヘキシル基等を例示できる。As mentioned above, the term hydroxy lower alkyl group refers to a linear or branched hydroxyalkyl group having 1 to 6 carbon atoms, examples of which include hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl. , 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 2-hydroxy-1-methylethyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl, 4-hydroxybutyl, 1-hydroxypentyl, 2-hydroxypentyl, 3-hydroxypentyl, 4-hydroxypentyl, 5-hydroxypentyl,
1-hydroxyhexyl, 2-hydroxyhexyl, 6
-Hydroxyhexyl group, etc. can be exemplified.
低級アルコキシカルボニル低級アルキル基なる語の例と
しては、例えばメトキシカルボニルメチル、エトキシカ
ルボニルメチル、プロポキシカルボニルメチル、イソプ
ロポキシカルボニルメチル、ブトキシカルボニルメチル
ボニルメチル、ヘキシルオキシカルボニルメチル、1−
メトキシカルボニルエチル
ルボニルエチル、3−メトキシカルボニルプロピル、2
−メトキシカルボニルブチル
シカルボニルブチル、3−メトキシカルボニルペンチル
、5−メトキシカルボニルペンチル、4−メトキシカル
ボニルヘキシル
ボニルヘキシル、4−エトキシカルボニルブチル、3−
(1−ブトキシ)カルボニルプロピル、6−(1−プロ
ポキシ)カルボニルヘキシル基等を例示できる。Examples of lower alkoxycarbonyl lower alkyl groups include methoxycarbonylmethyl, ethoxycarbonylmethyl, propoxycarbonylmethyl, isopropoxycarbonylmethyl, butoxycarbonylmethylbonylmethyl, hexyloxycarbonylmethyl, 1-
Methoxycarbonylethylcarbonylethyl, 3-methoxycarbonylpropyl, 2
-methoxycarbonylbutylsicarbonylbutyl, 3-methoxycarbonylpentyl, 5-methoxycarbonylpentyl, 4-methoxycarbonylhexylbonylhexyl, 4-ethoxycarbonylbutyl, 3-
Examples include (1-butoxy)carbonylpropyl and 6-(1-propoxy)carbonylhexyl groups.
カルボキシ低級アルキル基なる語の例としては、例えば
カルボキシメチル、1−カルボキシエチル、2−カルボ
キシエチル、2−カルボキシプロピル、3−カルボキシ
プロピル、2−カルボキシブチル、4−カルボキシブチ
ル、3−カルボキシペンチル、5−カルボキシペンチル
、3−カルボキシヘキシルキシル基等を例示できる。Examples of the term carboxy lower alkyl group include carboxymethyl, 1-carboxyethyl, 2-carboxyethyl, 2-carboxypropyl, 3-carboxypropyl, 2-carboxybutyl, 4-carboxybutyl, 3-carboxypentyl, Examples include 5-carboxypentyl and 3-carboxyhexylxyl groups.
ハロゲノ置換低級アルキル基なる語の具体例としては、
例えばフルオロメチル、ジフルオロメチル、トリフルオ
ロメチル、クロロメチル、ジクロロメチル、トリクロロ
メチル、ブロモメチル、ジブロモメチル、トリブロモメ
チル、ヨードメチル、ショートメチル、トリヨードメチ
ル、1−フルオロエチル、2−フルオロエチル、1,2
−ジフルオロエチル、2,2−ジフルオロエチル、1,
2−ジクロロエチル、2.2−ジクロロエチル、2−ク
ロロ−2−フルオロエチル、2−ブロモエチル、2.2
−ジブロモエチル、2.2.2−トリフルオロエチル、
1.3−ジフルオロプロピル、3、3.3−トリフルオ
ロエチル、3.3−ジクロロプロピル、2,4−ジブロ
モブチル、4。Specific examples of the term halogeno-substituted lower alkyl group include:
For example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl, iodomethyl, shortmethyl, triiodomethyl, 1-fluoroethyl, 2-fluoroethyl, 1, 2
-difluoroethyl, 2,2-difluoroethyl, 1,
2-dichloroethyl, 2.2-dichloroethyl, 2-chloro-2-fluoroethyl, 2-bromoethyl, 2.2
-dibromoethyl, 2.2.2-trifluoroethyl,
1,3-difluoropropyl, 3,3,3-trifluoroethyl, 3,3-dichloropropyl, 2,4-dibromobutyl, 4.
4、4−トリブロモブチル、4,4−ジフルオロブチル
、3.5−ジクロロペンチル、5,5−ジフルオロペン
チル、5.5.5−トリフルオロペンチル、6.6−ジ
ブロモヘキシル、6,6.ロートリフルオロヘキシル基
等を例示できる。4,4-tribromobutyl, 4,4-difluorobutyl, 3.5-dichloropentyl, 5,5-difluoropentyl, 5.5.5-trifluoropentyl, 6.6-dibromohexyl, 6,6. Examples include a rottrifluorohexyl group.
低級アルキルカルボニル基なる語の具体例としては、例
えばアセチル、エチルカルボニル、1−プロピルカルボ
ニル、2−プロピルカルボニル1−ブチルカルボニル、
2−ブチルカルボニル、t−ブチルカルボニル、1−ペ
ンチルカルボニル、2−ペンチルカルボニル
ボニル、3−へキシルカルボニル基等を例示できる。Specific examples of the lower alkylcarbonyl group include acetyl, ethylcarbonyl, 1-propylcarbonyl, 2-propylcarbonyl 1-butylcarbonyl,
Examples include 2-butylcarbonyl, t-butylcarbonyl, 1-pentylcarbonyl, 2-pentylcarbonyl, and 3-hexylcarbonyl.
低級アルキルチオ基なる語の具体例としては、例えばメ
チルチオ、エチルチオ、1−プロピルチオ、2−プロピ
ルチオ、1−ブチルチオ、2−ブチルチオ、【−ブチル
チオ、1−ペンチルチオ、2−ペンチルチオ、3−ペン
チルチオ、1−へキシルチオ、2−へキシルチオ、3−
ヘキシルチオ基等を例示できる。Specific examples of the term lower alkylthio include methylthio, ethylthio, 1-propylthio, 2-propylthio, 1-butylthio, 2-butylthio, [-butylthio, 1-pentylthio, 2-pentylthio, 3-pentylthio, 1- hexylthio, 2-hexylthio, 3-
Examples include hexylthio group.
更に、上記各基の1〜3個を置換基として有するフェニ
ル基の具体例としては、次に示す如き各基を例示するこ
とができる。Furthermore, as specific examples of the phenyl group having 1 to 3 of the above groups as substituents, the following groups can be exemplified.
2−フルオロフェニル、3−フルオロフェニル、4−フ
ルオロフェニル、2−クロロフェニル、3−クロロフェ
ニル、4−クロロフェニル、2−ブロモフェニル、3−
ブロモフェニル、4−ブロモフェニル、2−ヨードフェ
ニル、3−ヨードフェニル、4−ヨードフェニル、2.
4−ジフルオロフェニル、2.4−ジクロロフェニル、
2.4。2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-
Bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl, 2.
4-difluorophenyl, 2,4-dichlorophenyl,
2.4.
ロートリフルオロフェニル、2.4.6−トリクロロフ
エニル、2−ヒドロキシフェニル、3−ヒドロキシフェ
ニル、4−ヒドロキシフェニル、2。Lotrifluorophenyl, 2.4.6-Trichlorophenyl, 2-hydroxyphenyl, 3-hydroxyphenyl, 4-hydroxyphenyl, 2.
4−ジヒドロキシフェニル、2.4.6−トリヒドロキ
シフエニル、2−トリフルオロメチルフェニル、3−ト
リフルオロメチルフェニル、4ニトリフルオロメチルフ
エニル、3.5−ジ(トリフルオロメチル
ェニル
カルボキシメチルフェニル
シメチルフェニル、2−エトキシカルボニルメチルフェ
ニル、3−エトキシカルボニルメチルフェニル、4−エ
トキシカルボニルメチルフェニル、2、4−ジェトキシ
カルボニルメチルフェニル、2、4.6−ドリエトキシ
カルボニルメチルフエニル
ニル、4−メトキシフェニル、2.4−ジメトキシフェ
ニル、2.4.6−トリメトキシフェニル、3、4.5
−トリメトキシフェニル、2−エトキシフェニル、4−
エトキシフェニル、2.4−ジェトキシフェニル、2,
4.6−)−ジェトキシフェニル、2−カルボキシメチ
ルフェニルルボキシメチルフェニル、4−カルボキシメ
チルフェニル、2,4−ジカルボキシメチルフェニル、
2、4.6−t−ジカルボキシメチルフェニル、2−ア
セチルフェニル、3−アセチルフェニル、4−アセチル
フェニル、2.4−ジアセチルフェニル、2− (1−
カルボキシエチル)フェニル、3−(1−カルボキシエ
チル)フェニル、4−(1−カルボキシエチル)フェニ
ル、2.4−ジ(1−カルボキシエチル)フェニル、2
−(2−カルボキシエチル)フェニル、3−(2−カル
ボキシエチル)フェニル、4−(2−カルボキシエチル
)フェニル、2.4−ジー(2−カルボキシエチル)フ
ェニル、2−メチルチオフェニル、3−メチルチオフェ
ニル、4−メチルチオフェニル、2.4−ジメチルチオ
フェニル、2,4.6−トリメチルチオフェニル、3.
4.5−トリメチルチオフェニル、2−7ミノフエニル
、3−アミノフェニル、4−アミノフェニル、2.4−
ジアミノフェニル、2,4.6−トリアミノフェニル、
2−フェニルチオフェニル、3−フェニルチオフェニル
、4−フェニルチオフェニル、2− (1−ペンチルチ
オ)フェニル、3− (1−ペンチルチオ)フェニル、
4−(1−ペンチルチオ)フェニル、2。4-dihydroxyphenyl, 2.4.6-trihydroxyphenyl, 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-nitrifluoromethylphenyl, 3.5-di(trifluoromethylphenylcarboxymethylphenyl) Dimethylphenyl, 2-ethoxycarbonylmethylphenyl, 3-ethoxycarbonylmethylphenyl, 4-ethoxycarbonylmethylphenyl, 2,4-jethoxycarbonylmethylphenyl, 2,4.6-driethoxycarbonylmethylphenyl, 4 -methoxyphenyl, 2.4-dimethoxyphenyl, 2.4.6-trimethoxyphenyl, 3, 4.5
-trimethoxyphenyl, 2-ethoxyphenyl, 4-
Ethoxyphenyl, 2,4-jethoxyphenyl, 2,
4.6-)-jethoxyphenyl, 2-carboxymethylphenylruboxymethylphenyl, 4-carboxymethylphenyl, 2,4-dicarboxymethylphenyl,
2, 4.6-t-dicarboxymethylphenyl, 2-acetylphenyl, 3-acetylphenyl, 4-acetylphenyl, 2.4-diacetylphenyl, 2- (1-
Carboxyethyl)phenyl, 3-(1-carboxyethyl)phenyl, 4-(1-carboxyethyl)phenyl, 2.4-di(1-carboxyethyl)phenyl, 2
-(2-carboxyethyl)phenyl, 3-(2-carboxyethyl)phenyl, 4-(2-carboxyethyl)phenyl, 2,4-di(2-carboxyethyl)phenyl, 2-methylthiophenyl, 3-methylthio Phenyl, 4-methylthiophenyl, 2.4-dimethylthiophenyl, 2,4.6-trimethylthiophenyl, 3.
4.5-trimethylthiophenyl, 2-7minophenyl, 3-aminophenyl, 4-aminophenyl, 2.4-
Diaminophenyl, 2,4,6-triaminophenyl,
2-phenylthiophenyl, 3-phenylthiophenyl, 4-phenylthiophenyl, 2-(1-pentylthio)phenyl, 3-(1-pentylthio)phenyl,
4-(1-pentylthio)phenyl, 2.
4−ジー(1−ペンチルチオ)フェニル、2−メチルフ
ェニル、3−メチルフェニル、4−メチルフェニル、2
.4−ジメチルフェニル、2.4。4-di(1-pentylthio)phenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2
.. 4-dimethylphenyl, 2.4.
6−トリメチルフエニル、2− (1−ブチル)フェニ
ル、3−(1−ブチル)フェニル、4−(1−ブチル)
フェニル、2.4−ジ(1−ブチル)フェニル、2.4
.6−トリー(1−ブチル)フェニル、3−クロロ−2
−ヒドロキシフェニル、4−クロロ−2−ヒドロキシフ
ェニル、5−クロロー2−ヒドロキシフェニル、6−ク
ロロ−2−ヒドロキシフェニル、4−クロロ−3−ヒド
ロキシフェニル、5−クロロ−3−ヒドロキシフェニル
、2−(3−カルボキシプロピル)フェニル、3−(3
−カルボキシプロピル)フェニル、4−(3−カルボキ
シプロピル
ジ(3−カルボキシプロピル)フェニル、2−ヒトOキ
シー4ーカルボキシメチルフェニルヒドロキシ−5−カ
ルボキシメチルフェニル−ヒドロキシ−6−カルボキシ
メチルフェニル、3−ヒドロキシ−5−カルボキシメチ
ルフェニル、2−カルボキシフェニル、3−カルボキシ
フェニル、4−カルボキシフェニル、3.5−ジカルボ
キシフェニル、2−クロロ−6−カルボキシフェニル、
4−クロロ−6−カルボキシフェニル、2−クロo−4
−カルボキシフェニル、3−クロロ−5−カルボキシフ
ェニル、2−シアノフェニル、3−シアノフェニル、4
−シアノフェニル、3。6-trimethylphenyl, 2-(1-butyl)phenyl, 3-(1-butyl)phenyl, 4-(1-butyl)
Phenyl, 2.4-di(1-butyl)phenyl, 2.4
.. 6-tri(1-butyl)phenyl, 3-chloro-2
-Hydroxyphenyl, 4-chloro-2-hydroxyphenyl, 5-chloro-2-hydroxyphenyl, 6-chloro-2-hydroxyphenyl, 4-chloro-3-hydroxyphenyl, 5-chloro-3-hydroxyphenyl, 2- (3-carboxypropyl)phenyl, 3-(3
-carboxypropyl)phenyl, 4-(3-carboxypropyldi(3-carboxypropyl)phenyl, 2-humanOxy4-carboxymethylphenylhydroxy-5-carboxymethylphenyl-hydroxy-6-carboxymethylphenyl, 3- Hydroxy-5-carboxymethylphenyl, 2-carboxyphenyl, 3-carboxyphenyl, 4-carboxyphenyl, 3.5-dicarboxyphenyl, 2-chloro-6-carboxyphenyl,
4-chloro-6-carboxyphenyl, 2-chloro-o-4
-carboxyphenyl, 3-chloro-5-carboxyphenyl, 2-cyanophenyl, 3-cyanophenyl, 4
-cyanophenyl, 3.
5−ジシアノフェニル、2,4.6−トリシアノフエニ
ル、4−メチル−2−カルボキシフェニル、6−メチル
−2−カルボキシフェニル、2−メチル−4−カルボキ
シフェニル
カルポキシフェニル、4−ヒドロキシ−3−カルボキシ
フェニル、4−ヒドロキシ−2−カルボキシフェニル、
6−ヒドロキシ−2−カルボキシフェニル、2−ヒドロ
キシメチルフェニル、3−ヒドロキシメチルフェニル、
4−ヒドロキシメチルフェニル、2.6ージ(ヒドロキ
シメチル)フェニル、2,4.6ートリ(ヒドロキシメ
チル)フェニル、2−(2−ヒドロキシエチル)フェニ
ル、3−(2−ヒドロキシエチル)フェニル、4−(2
−ヒドロキシエチル)フェニル、3.5−ジ(2−ヒド
ロキシエチル)フェニル、2−(1−ヒドロキシエチル
)フェニル、3−(1−ヒドロキシエチル)フェニル、
4−(1−ヒドロキシエチル)フェニル、2.4−ジ(
1−ヒドロキシエチル)フェニル、2.4.6−t−リ
(1−ヒドロキシエチル)フェニル、2− (3−ヒド
ロキシプロピル)フェニル、3−(3−ヒドロキシプロ
ピル)フェニル、4− (3−ヒドロキシプロピル)フ
ェニル、3,5−ジ(3−ヒドロキシプロピル)フェニ
ル、2,4−ジ(3−ヒドロキシプロピル)フェニル、
2− (4−ヒドロキシブチル)フェニル、3−(4−
ヒドロキシブチル)フェニル、4−(4−ヒドロキシブ
チル)フェニル、2.4−ジ(4−ヒドロキシブチル)
フェニル、2−(1−ヒドロキシイソプロピル)フェニ
ル、3−(1−ヒドロキシイソプロピル)フェニル、4
− (1−ヒドOキシイソプロピル)フェニル、2.6
ージ(1−ヒドロキシイソプロピル)フェニル、2−ク
ロロ−6−ヒドロキシメチルフェニル、3−クロロ−6
−ヒドロキシメチルフェニル、4−クロロ−6−とドロ
キシメチルフェニル、2−クロロ−4−ヒドロキシメチ
ルフェニル、2−クロロ−5−ヒドロキシメチルフェニ
ル、2−ヒドロキシ−4−(2−ヒドロキシエチル)フ
ェニル、2−ヒドロキシ−5−(2−ヒドロキシエチル
)フェニル、2−ヒドロキシ−6−(2−ヒドロキシエ
チル)フェニル、3−ヒドロキシ−5−(2−ヒドロキ
シエチル)フェニル、6−メチル−2−(ヒドロキシメ
チル)フェニル、5−メチル−2−(ヒドロキシメチル
)フェニル、4−メチル−2−(ヒドロキシメチル)フ
ェニル、2−メチル−4−(ヒドロキシメチル)フェニ
ル基等。5-dicyanophenyl, 2,4.6-tricyanophenyl, 4-methyl-2-carboxyphenyl, 6-methyl-2-carboxyphenyl, 2-methyl-4-carboxyphenylcarpoxyphenyl, 4-hydroxy-3 -carboxyphenyl, 4-hydroxy-2-carboxyphenyl,
6-hydroxy-2-carboxyphenyl, 2-hydroxymethylphenyl, 3-hydroxymethylphenyl,
4-hydroxymethylphenyl, 2.6-di(hydroxymethyl)phenyl, 2,4.6-tri(hydroxymethyl)phenyl, 2-(2-hydroxyethyl)phenyl, 3-(2-hydroxyethyl)phenyl, 4 −(2
-hydroxyethyl)phenyl, 3.5-di(2-hydroxyethyl)phenyl, 2-(1-hydroxyethyl)phenyl, 3-(1-hydroxyethyl)phenyl,
4-(1-hydroxyethyl)phenyl, 2,4-di(
1-hydroxyethyl)phenyl, 2.4.6-t-li(1-hydroxyethyl)phenyl, 2-(3-hydroxypropyl)phenyl, 3-(3-hydroxypropyl)phenyl, 4-(3-hydroxy propyl)phenyl, 3,5-di(3-hydroxypropyl)phenyl, 2,4-di(3-hydroxypropyl)phenyl,
2-(4-hydroxybutyl)phenyl, 3-(4-
hydroxybutyl)phenyl, 4-(4-hydroxybutyl)phenyl, 2,4-di(4-hydroxybutyl)
Phenyl, 2-(1-hydroxyisopropyl)phenyl, 3-(1-hydroxyisopropyl)phenyl, 4
- (1-HydoOxyisopropyl)phenyl, 2.6
-di(1-hydroxyisopropyl)phenyl, 2-chloro-6-hydroxymethylphenyl, 3-chloro-6
-Hydroxymethylphenyl, 4-chloro-6- and droxymethylphenyl, 2-chloro-4-hydroxymethylphenyl, 2-chloro-5-hydroxymethylphenyl, 2-hydroxy-4-(2-hydroxyethyl)phenyl , 2-hydroxy-5-(2-hydroxyethyl)phenyl, 2-hydroxy-6-(2-hydroxyethyl)phenyl, 3-hydroxy-5-(2-hydroxyethyl)phenyl, 6-methyl-2-( hydroxymethyl)phenyl, 5-methyl-2-(hydroxymethyl)phenyl, 4-methyl-2-(hydroxymethyl)phenyl, 2-methyl-4-(hydroxymethyl)phenyl, and the like.
本発明の上記一般式(1)で表わされる化合物及びその
塩は、プロスタグランジン生合成の遮断作用や調節作用
及び脂質低下作用を有し、動物、とりわけ哺乳動物に対
して、抗炎症、抗リウマチ、抗アレルギー、鎮痛、利尿
、血小板凝集阻止、血圧降下及び抗高脂血症作用を示す
。従ってこれは、抗炎症剤、抗リウマチ剤、抗アレルギ
ー剤、鎮痛剤、利尿剤、抗血栓剤、降圧剤及び抗高脂血
症剤等の医薬として有用である。The compound represented by the above general formula (1) of the present invention and its salt have an effect of blocking or regulating prostaglandin biosynthesis and a hypolipidemic effect, and have anti-inflammatory and anti-inflammatory effects on animals, especially mammals. Shows rheumatism, antiallergy, analgesia, diuresis, platelet aggregation inhibition, blood pressure lowering, and antihyperlipidemic effects. Therefore, it is useful as a medicine such as an anti-inflammatory agent, an anti-rheumatic agent, an anti-allergy agent, an analgesic, a diuretic, an antithrombotic agent, an antihypertensive agent, and an antihyperlipidemic agent.
本発明化合物は、例えば下記各反応工程式に示す方法に
より製造することができる。The compounds of the present invention can be produced, for example, by the methods shown in the following reaction schemes.
〈反応工程式−1〉
(式中R1、R2及びR3は前記に同じ。〕反反応工程
−1によれば、ベンゾキノン誘導体(2)とアニリン誘
導体(3)との縮合反応及びこれに引続く還元操作によ
り、本発明化合物(1)を収得できる。<Reaction scheme-1> (In the formula, R1, R2, and R3 are the same as above.) According to reaction process-1, the condensation reaction between the benzoquinone derivative (2) and the aniline derivative (3) and the subsequent Compound (1) of the present invention can be obtained by reduction operation.
上記縮合反応は、公知の方法、例えばライカーら(A、
Re1ker et al)によるテトラヘドロ
ン(Tetrahedron) 、第23巻、3723
頁(1967年)に記載の方法やフイグエラスら(J
、 F igueras et al)によるジャ
ーナルオブ オーガニック ケミストリー(J、Org
。The above condensation reaction can be carried out using known methods such as Riker et al.
Tetrahedron by Reker et al., Volume 23, 3723
(1967) and Fuiguelas et al.
, F igueras et al) in the Journal of Organic Chemistry (J, Org.
.
Chew、)、36.3497 (1971)に記載の
方法に準じて実施できる。より詳細には上記縮合反応は
、酢酸、BF3 ・Et20等を触媒として、化合物(
2)に対して化合物(3)を1〜5倍モル量使用し、無
溶媒もしくは例えばテトラヒドロフラン(THF)、エ
ーテル、ジオキサン、クロロホルム、1,2−ジクロロ
エタン、ベンゼン、トルエン、キシレン等の適当な溶媒
中、約30〜200℃の温度範囲で実施される。Chew, ), 36.3497 (1971). More specifically, the above condensation reaction is carried out using acetic acid, BF3 ・Et20, etc. as a catalyst to form a compound (
Compound (3) is used in an amount of 1 to 5 times the molar amount of 2), and either no solvent or an appropriate solvent such as tetrahydrofuran (THF), ether, dioxane, chloroform, 1,2-dichloroethane, benzene, toluene, xylene, etc. It is carried out in a temperature range of about 30 to 200°C.
上記により得られる化合物(4)は、これを反応系内よ
り単離することなく、引続く還元反応に供することがで
きるが、勿論単離してもよい。Compound (4) obtained as described above can be subjected to the subsequent reduction reaction without being isolated from the reaction system, but may of course be isolated.
還元反応は、通常の方法に従い、例えば上記反応生成物
を水中に移し、2〜50倍モル量のハイドロサルファイ
ド(Na 2320t )水溶液を添加することにより
実施できる。また上記還元反応は、化合物(4)の有す
るR1基の置換基の種類に応じて、例えば酢酸中で亜鉛
末を用いる方法、酢酸エチル、アルコール、THF、水
等の溶媒中でパラジウム−炭素ヤP t O2を触媒と
して接触水添する方法等によっても実施することができ
る。The reduction reaction can be carried out according to a conventional method, for example, by transferring the above reaction product into water and adding an aqueous solution of hydrosulfide (Na 2320t ) in a 2 to 50-fold molar amount. Depending on the type of substituent of the R1 group of compound (4), the above reduction reaction can be carried out, for example, by using zinc powder in acetic acid, or by using palladium-carbon film in a solvent such as ethyl acetate, alcohol, THF, or water. It can also be carried out by a method of catalytic hydrogenation using P t O2 as a catalyst.
更に本発明化合物(1)においてR1がヒドロキシ低級
アルキル基を有するフェニル基である化合物は、上記方
法に従い得られるR1がカルボキシ低級アルキル基を有
するフェニル基又は低級アルコキシカルボニル低級アル
キル基を有するフェニル基である化合物(1)を、例え
ばエーテル、THF等の適当な溶媒中、約1〜7倍モル
量のLiAIHzで還元するか、或いはR1が低級アル
キルカルボニル基を有するフェニル基である化合物(1
)を、例えばメタノール、エタノール、イソプロパツー
ル及び之等とTHF、ジオキサン等との混合溶媒等の適
当な溶媒中、約1.5〜5倍モル量のNa BHzで還
元することによっても収得することができる。Furthermore, in the compound (1) of the present invention, R1 is a phenyl group having a hydroxy lower alkyl group, and R1 obtained according to the above method is a phenyl group having a carboxy lower alkyl group or a phenyl group having a lower alkoxycarbonyl lower alkyl group. A certain compound (1) is reduced with about 1 to 7 times the molar amount of LiAIHz in a suitable solvent such as ether or THF, or a compound (1) in which R1 is a phenyl group having a lower alkylcarbonyl group is reduced.
) in a suitable solvent such as a mixed solvent of methanol, ethanol, isopropanol, etc. with THF, dioxane, etc., with about 1.5 to 5 times the molar amount of NaBHz. be able to.
上記各反応により得られる本発明化合物(1)は、慣用
される分離手段、例えば溶媒抽出、再結晶、カラムクロ
マトグラフィー等により容易に単離、精製することがで
きる。The compound (1) of the present invention obtained by each of the above reactions can be easily isolated and purified by conventional separation means such as solvent extraction, recrystallization, column chromatography, etc.
また、本発明化合物(1)は、これに適当な散性化合物
を付加反応させることにより、医薬的に許容される酸付
加塩とすることができ、本発明はかかる酸付加塩をも包
含する。上記酸付加塩を形成し得る酸性化合物としては
、例えば塩漬、硫酸、リン酸、臭化水素ひ等の無曙酸及
びシュウ酸、マレイン酸、フマール酸、リンゴ酸、酒石
醒、クエン酸、安息香酸等の有磯酸を例示できる。更に
本発明化合物中、遊離のカルボキシル基を有するものは
、これを常法に従いアルカリ金属塩、例えばナトリウム
塩、カリウム塩等、アルカリ土類金属塩、例えばカルシ
ウム塩、マグネシウム塩等、その他銅塩等とすることが
でき、これらも遊離形態の本発明化合物と同様の薬理活
性を有しており、本発明範囲内に包含される。Furthermore, the compound (1) of the present invention can be made into a pharmaceutically acceptable acid addition salt by subjecting it to an addition reaction with a suitable dispersible compound, and the present invention also includes such acid addition salts. . Examples of acidic compounds that can form the above-mentioned acid addition salts include salting, sulfuric acid, phosphoric acid, anhydrous and oxalic acids such as hydrogen bromide, maleic acid, fumaric acid, malic acid, tartaric acid, and citric acid. , and isoacids such as benzoic acid. Furthermore, among the compounds of the present invention, those having a free carboxyl group may be treated with alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and magnesium salts, and other copper salts. These also have the same pharmacological activity as the free form of the compound of the present invention and are included within the scope of the present invention.
実 施 例
以下、本発明を更に詳しく説明するため実施例を挙げる
。EXAMPLES Examples will be given below to explain the present invention in more detail.
実施例1
4−(4−フルオロフェニルアミノ)−2゜6一ジー℃
−ブチルフェノールの製造
2.6−ジー【−ブチル−1,4−ベンゾキノン2.2
g及びp−フルオロアニリン3.3gを、THF60−
に溶解し、これにBF3 ・Et20の0.3mQを加
え6時間速流した。6後、水5゜−を加え、次いでNa
2820420g17)水150m溶液を、室温下に
加え、反応混合物の赤色が消失するまで約15分間、撹
拌を続けた。その後、水に移し、エチルエーテルで抽出
し、有機層を飽和食塩水で洗浄し、fVNlsOtで乾
燥し、濃縮して得られる粗生成物を、カラムクロマトグ
ラフィー(Et20:ヘキサン−1:10)で精製して
、目的化合物2gを得た。Example 1 4-(4-fluorophenylamino)-2°6-di℃
-Production of butylphenol 2.6-di[-butyl-1,4-benzoquinone 2.2
3.3 g of g and p-fluoroaniline were added to THF60-
0.3 mQ of BF3.Et20 was added thereto and the mixture was rapidly flowed for 6 hours. After 6 hours, add 5° of water, then add Na
2820420g17) A 150ml solution of water was added at room temperature, and stirring was continued for about 15 minutes until the red color of the reaction mixture disappeared. Thereafter, it was transferred to water, extracted with ethyl ether, and the organic layer was washed with saturated brine, dried with fVNlsOt, and concentrated. After purification, 2 g of the target compound was obtained.
得られた化合物の物性は、第1表にN051として示す
。The physical properties of the obtained compound are shown in Table 1 as N051.
実施例2〜23
実施例1と同様にして、第1表に示す化合物N002〜
11を製造した。Examples 2-23 Compounds N002- shown in Table 1 were prepared in the same manner as in Example 1.
11 were manufactured.
また、同様にして化合物N0.12〜23の遊離ベース
を製造し、之等にそれぞれ4Nの塩酸/酢酸エチルを加
えて、塩酸塩の形態の目的化合物のそれぞれを得た。In addition, the free bases of Compounds No. 12 to 23 were prepared in the same manner, and 4N hydrochloric acid/ethyl acetate was added to each of them to obtain each of the target compounds in the form of hydrochloride.
得られた各化合物の物性を第1表に示す。Table 1 shows the physical properties of each compound obtained.
実施例24
4−(3−カルボキシフェニルアミノ
6−ジーt−ブチルフェノールの製造
2、6−ジーt−ブチル−1.4−ベンゾキノン6、6
g,1−7ミノ安息香駿4.2g及び酢I!6滴を、2
時間加熱撹拌した後、放冷し、次いで反応混合物に本釣
50鯨を加え、更に、THF200mを加え、更にNa
2 S2 0h 50CIの水30〇−溶液を室温で
加え、赤色が褪色するまで約15分間撹拌し、その後、
水に移し、酢酸エチルで抽出し、有機層を実施VA1と
同様に処理し、カラムクロマトグラフィー<CH2 C
Q2 :THF−5 : 1 )で精製して、目的化
合物6.70を得た。Example 24 Preparation of 4-(3-carboxyphenylamino 6-di-t-butylphenol) 2,6-di-t-butyl-1,4-benzoquinone 6,6
g, 1-7 Minobenzo Shun 4.2g and Vinegar I! 6 drops, 2
After heating and stirring for an hour, the reaction mixture was allowed to cool, and then 50 whales were added to the reaction mixture, followed by 200 m of THF, and further Na
2 S2 0h Add 300 ml of 50 CI in water at room temperature and stir for about 15 minutes until the red color fades, then
Transferred to water, extracted with ethyl acetate, treated the organic layer as in run VA1, column chromatography <CH2C
Q2:THF-5:1) to obtain the target compound 6.70.
得られた化合物の物性を、第1表に化合物No。The physical properties of the obtained compounds are shown in Table 1. Compound No.
24として示す。24.
実施例25〜30 実施例24と同様にして、第1表に化合物NO。Examples 25-30 Compound No. 1 is shown in Table 1 in the same manner as in Example 24.
25〜29として示す各化合物を得た。Compounds designated as 25 to 29 were obtained.
また、同様にして化合物No.30の遊離ベースを製造
し、これに4N塩酸/酢酸エチルを加えて、塩酸塩の形
態の目的化合物を得た。Similarly, compound No. The free base of 30 was prepared and 4N hydrochloric acid/ethyl acetate was added to it to obtain the desired compound in the form of the hydrochloride salt.
実施例31
4−(3−ヒドロキシメチルフェニルアミノ)−2.6
−ジーt−ブチルフェノール・塩酸塩の製造
実施例24で得られた4−(3−カルボキシフェニルア
ミノ)−2.6−ジーt−ブチルフェノール1.8gを
、THF30−に溶解し、その溶液を、Li AQHt
1.7Qのエチルエーテル150鵬懸濁液中に撹拌下
、室温にて滴下し、次いで反応混合物を3.5時間還流
した。6後、含水エチルエーテル、次いで水を用いて過
剰のLiAQH↓を注意深く分解し、有機層を分取し、
MQSOhで乾燥し、S縮して得られる粗生成物を、再
びエチルエーテル100maに溶かし、これに4Nの塩
1m/酢酸エチル溶液6−を加え、析出した結晶を戸数
し、エチルエーテルで洗浄し、風乾して、目的化合物1
.5gを得た。Example 31 4-(3-hydroxymethylphenylamino)-2.6
-Production of di-t-butylphenol hydrochloride 1.8 g of 4-(3-carboxyphenylamino)-2.6-di-t-butylphenol obtained in Example 24 was dissolved in 30-THF, and the solution was Li AQHt
It was added dropwise into a 1.7Q suspension of ethyl ether 150 at room temperature under stirring, and the reaction mixture was then refluxed for 3.5 hours. After 6, excess LiAQH↓ was carefully decomposed using aqueous ethyl ether and then water, and the organic layer was separated.
The crude product obtained by drying with MQSOh and S condensation was dissolved again in 100 mA of ethyl ether, and to this was added 1 m of 4N salt/ethyl acetate solution, and the precipitated crystals were separated and washed with ethyl ether. , air-dried, target compound 1
.. 5g was obtained.
該化合物の物性を化合物No.31として第1表に示す
。The physical properties of the compound were determined using Compound No. 31 in Table 1.
実施例32〜40
実施例31と同様の操作により、第1表に示す化合物N
o.32〜40を得た。Examples 32-40 Compound N shown in Table 1 was prepared by the same operation as in Example 31.
o. 32-40 were obtained.
実施例41
4−(3−α−メチルヒドロキシメチルフェニルアミノ
)−2.6−ジーt−ブチルフェノール・塩酸塩の製造
実施例10で得られた4−(3−アセチルフェニルアミ
ノ)−2.6−ジーt−ブチルフェノール(化合物N0
.10)lを、エタノール17田及びTI−IF12に
溶解し、これに水冷撹拌下にNa BH4 20011
;lをゆっくり加え、次いで反応混合物を1時間撹拌し
た。反応混合物を水に移し、エチルエーテルで抽出し、
有は層の黄赤色が退色するまで、有機層を10%Na2
S20&水溶液で洗浄し、次に飽和食塩水で洗浄し、M
gsotで乾燥し、約100tl12に濃縮した後、4
N塩酸/酢酸工チル溶液6mGを加え、析出した結晶を
戸数し、エチルエーテルで洗浄し、風乾して目的化合物
1gを得た。Example 41 Production of 4-(3-α-methylhydroxymethylphenylamino)-2.6-di-t-butylphenol hydrochloride 4-(3-acetylphenylamino)-2.6 obtained in Example 10 -di-t-butylphenol (compound N0
.. 10) 1 was dissolved in ethanol 17 and TI-IF12, and Na BH4 20011 was added to this while stirring with water cooling.
;1 was added slowly and the reaction mixture was stirred for 1 hour. The reaction mixture was transferred to water, extracted with ethyl ether,
The organic layer was diluted with 10% Na2 until the yellow-red color of the layer faded.
Wash with S20 & aqueous solution, then wash with saturated saline, M
After drying with gsot and concentrating to about 100 tl, 4
6 mg of N-hydrochloric acid/ethyl acetate solution was added, and the precipitated crystals were separated, washed with ethyl ether, and air-dried to obtain 1 g of the target compound.
該化合物の物性を下記第1表に化合物No.41として
示す。The physical properties of the compounds are shown in Table 1 below. 41.
第 1 表
t−3u
(以 上)
手続補正書(ffl制
昭和60年9り!1日
昭和60年 特 許 願第168175 号2、 発
明(D名称 ジ低級アル+ルフェノール誘導体3、補
正をする者
事件との関係 特許出願人
**−カ4.よ0. 夕古:j+−
、、、、/
4、代理人
大阪市東区平野町2の10沢の鶴ビル電話06−203
−0941 (代)7・ M正(7)対i、細書中「発
明。詳、ヶ、副。項8、補正の内容
補 正 の 内 容
(1)明細書第32頁に記載の第1表中化合物ム360
R1の項の記載を次の通)訂正する。No. 1 Table t-3u (above) Procedural amendment (ffl system September 1985! 1, 1985 Patent Application No. 168175 2, Invention (D name: di-lower alkylphenol derivative 3, amendment) Relationship with the patent applicant case
,,,,,/ 4. Agent: 10 Sawa no Tsuru Building, 2 Hirano-cho, Higashi-ku, Osaka Phone: 06-203
-0941 (Representative) 7, M. (7) v. I, ``Invention. Details, details, subsections. Section 8, Contents of amendment (1) Item 1 stated on page 32 of the specification. Compound M360 in the table
The description in section R1 is corrected as follows.
[ (CI2)2 H Cjl1m#1”) ヨ (以 上) A1n−[ (CI2)2 H Cjl1m#1”) Yo (that's all) A1n-
Claims (1)
、アミノ基、シアノ基、低級アルキル基、低級アルコキ
シ基、ヒドロキシ低級アルキル基、低級アルコキシカル
ボニル低級アルキル基、カルボキシ低級アルキル基、ハ
ロゲノ置換低級アルキル基、低級アルキルカルボニル基
、低級アルキルチオ基及びフェニルチオ基から選ばれる
置換基の1〜3個を有するフェニル基を示す。R^2及
びR^3は各々同一又は異なつて低級アルキル基を示す
。〕 で表わされるジ低級アルキルフェノール誘導体及びその
塩。(1) General formula▲ Numerical formula, chemical formula, table, etc.▼ [In the formula, R^1 is a halogen atom, carboxyl group, hydroxyl group, amino group, cyano group, lower alkyl group, lower alkoxy group, hydroxy lower alkyl group, A phenyl group having 1 to 3 substituents selected from an alkoxycarbonyl lower alkyl group, a carboxy lower alkyl group, a halogeno-substituted lower alkyl group, a lower alkylcarbonyl group, a lower alkylthio group, and a phenylthio group. R^2 and R^3 are each the same or different and represent a lower alkyl group. ] A di-lower alkylphenol derivative represented by these and its salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16817585A JPS6229557A (en) | 1985-07-29 | 1985-07-29 | Dilower alkylphenol derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16817585A JPS6229557A (en) | 1985-07-29 | 1985-07-29 | Dilower alkylphenol derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6229557A true JPS6229557A (en) | 1987-02-07 |
JPH0576462B2 JPH0576462B2 (en) | 1993-10-22 |
Family
ID=15863183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16817585A Granted JPS6229557A (en) | 1985-07-29 | 1985-07-29 | Dilower alkylphenol derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6229557A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0491287A (en) * | 1990-07-30 | 1992-03-24 | Mitsubishi Heavy Ind Ltd | Apparatus for forming paper layer of paper machine |
US5416113A (en) * | 1985-07-22 | 1995-05-16 | Riker Laboratories, Inc. | Substituted di-t-butylphenols |
US7750156B2 (en) | 2004-03-25 | 2010-07-06 | Otsuka Pharmaceutical Co., Ltd. | Method of producing aminophenol compounds |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5349022A (en) * | 1976-10-15 | 1978-05-04 | Shin Nisso Kako Co Ltd | Novel fluorane derivatives |
US4200432A (en) * | 1974-02-22 | 1980-04-29 | L'oreal | Dye composition containing oxidation dye and diphenylamine |
JPS6270351A (en) * | 1985-07-22 | 1987-03-31 | ライカ− ラボラトリ−ス インコ−ポレ−テツド | Substituted di-t-butylphenols |
-
1985
- 1985-07-29 JP JP16817585A patent/JPS6229557A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200432A (en) * | 1974-02-22 | 1980-04-29 | L'oreal | Dye composition containing oxidation dye and diphenylamine |
JPS5349022A (en) * | 1976-10-15 | 1978-05-04 | Shin Nisso Kako Co Ltd | Novel fluorane derivatives |
JPS6270351A (en) * | 1985-07-22 | 1987-03-31 | ライカ− ラボラトリ−ス インコ−ポレ−テツド | Substituted di-t-butylphenols |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5416113A (en) * | 1985-07-22 | 1995-05-16 | Riker Laboratories, Inc. | Substituted di-t-butylphenols |
JPH0491287A (en) * | 1990-07-30 | 1992-03-24 | Mitsubishi Heavy Ind Ltd | Apparatus for forming paper layer of paper machine |
US7750156B2 (en) | 2004-03-25 | 2010-07-06 | Otsuka Pharmaceutical Co., Ltd. | Method of producing aminophenol compounds |
Also Published As
Publication number | Publication date |
---|---|
JPH0576462B2 (en) | 1993-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4110337A (en) | Triazolobenzodiazepines | |
HU198905B (en) | Process for production of derivatives of 4-/alkyl-sulphonil/-3-hydroxi-2-chlor bensoic acid | |
US4829058A (en) | Substituted bis-(4-aminophenyl)-sulfones | |
JPS6229557A (en) | Dilower alkylphenol derivative | |
IE56652B1 (en) | Antihypertensive n-piperazinylalkanoylanilides | |
KR920000956B1 (en) | Process for the preparation of azulene derivarives | |
US4325964A (en) | Phenylamidine derivatives | |
PL163044B1 (en) | Method of obtaining substituted diketones | |
PL190265B1 (en) | Method of obtaining 2-aryl-3-aryl-halopyridines useful as cox-2 inhibitors | |
US4968808A (en) | Process for the preparation of nitroethene derivatives | |
DE60012587T2 (en) | FRIEDEL-CRAFT PROCESS FOR THE PREPARATION OF THIOXANTHONES | |
US4081451A (en) | Process for preparing 2-halogeno nicotinic acids | |
US4016223A (en) | Prostaglandin dehydrogenase inhibiting agents | |
JP2620316B2 (en) | Preparation of α, β-substituted acrolein | |
JPH01156965A (en) | Thiohydantoin compound | |
AU676773B2 (en) | Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues | |
JPH0291043A (en) | Preparation of salicylic acid derivative | |
US4038415A (en) | Prostaglandin dehydrogenase inhibiting agents | |
King et al. | 248. Antiplasmodial action and chemical constitution. Part III. Carbinolamines derived from naphthalene and quinoline | |
NZ213128A (en) | Process for production of sorbinil and its 2-methyl derivative and the intermediate compounds and compounds themselves | |
CA2649506C (en) | 2-alkenyl-3-aminothiophene derivative and process for producing thereof | |
US5739382A (en) | Derivatives of 2-aminobenzenesulphonic acid and of 2-aminobenzenesulphonyl chloride, their preparation and their use as synthetic intermediates | |
EP0206611B1 (en) | 3-(4-fluorophenoxy)-1-propanol | |
NO139782B (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 3-BENZOYLPHENYLACIC ACID OR 2- (3-BENZOYLPHENYL) PROPHIC ACID | |
EP0852578B1 (en) | Method for preparing certain acetonitriles |